In the BioHarmony Drug Report Database

"Preview" Icon

Insulin lispro

Admelog, Humalog, Liprolog, Liumjev, Lyumjev (insulin lispro) is a protein pharmaceutical. Insulin lispro was first approved as Admelog on 1996-04-30. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.


Trade Name


Humalog, Liprolog, Liumjev, Lyumjev

Common Name


insulin lispro






diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus

Drug Class


Image (chem structure or protein)

Insulin lispro structure rendering